Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04778631
Other study ID # En cours-
Secondary ID 2020-A03399-30
Status Recruiting
Phase N/A
First received
Last updated
Start date May 16, 2022
Est. completion date June 2023

Study information

Verified date September 2022
Source Assistance Publique - Hôpitaux de Paris
Contact Anne CHANTRY, RM & PhD
Phone 01 42 34 55 80
Email anne.chantry@inserm.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Perineal pain is common after vaginal birth. Thermotherapy might be effective to limit postpartum perineal pain, thanks to the effects of local heating or cooling application. This study aims to evaluate the impact of thermotherapy during childbirth on postpartum perineal pain.


Description:

Perineal lesions are common during vaginal delivery: 52% of women giving birth in France experience perineal lesions and 20% an episiotomy. Obstetrical anal sphincter injuries (OASIS) are the most feared due to the risk of anal incontinence, but they concerned a minority of women (0.8%). For most of the women with simple lesions of the perineum, the primary consequence is pain. This moderate to severe perineal pain affects between 40% and 95% of women and peaks in intensity the day after childbirth. This pain might be disabling, impair the mobility, the establishment of breastfeeding, the mother-infant bond, alter the emotional state and overall might affect the quality of life of mothers. Thermotherapy provides a minimally invasive and inexpensive alternative to limit perineal pain in postpartum, thanks to the effects of local heating or cooling application to the perineum : - Heat therapy with warm compresses, to protect the perineum during active second stage of labor and reduce the degree of perineal injury : the application promotes vasodilation and extensibility of tissues; - Cryotherapy with instant cold pack, to prevent the onset of pain in the immediate postpartum period: the application limits the development of oedema or hematoma. Midwives frequently use thermotherapy with heat or cold. However, these practices cannot be recommended due to a lack of data. Moreover, the potentially synergic effect of consecutive application of heat and cold therapy into the perineum during active second stage of labor and immediate postpartum period has never been evaluated. We hypothesize that thermotherapy during childbirth may reduce postpartum perineal pain.


Recruitment information / eligibility

Status Recruiting
Enrollment 222
Est. completion date June 2023
Est. primary completion date April 2023
Accepts healthy volunteers No
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Primiparous women or multiparous women without history of vaginal birth - singleton fetus - fetal cephalic presentation - =37 gestational weeks - active labor (cervical dilatation = 6 cm) - living fetus - major female Exclusion Criteria - Abnormal fetal heart rate requiring hastening childbirth - Fetal malformation, stillbirth - History of female genital mutilation - Women not understanding French - Women with psychiatric condition - Anonymous childbirth - Minor female - No affiliation to a social security scheme (beneficiary or assignee)

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Heat therapy
Application of warm compresses, soaked in hot tap water (between 38° and 44 °C), to the perineum, at each contraction or pushing effort from the start of perineum distension until birth.
Cryotherapy
Application of a perineal instant col pack to the perineum, after placental delivery or perineum suturing, for at least 20 minutes.

Locations

Country Name City State
France Louis Mourier Hospital Colombes
France Cochin Hospital Paris

Sponsors (4)

Lead Sponsor Collaborator
Assistance Publique - Hôpitaux de Paris Fondation Apicil, Institut National de la Santé Et de la Recherche Médicale, France, PRIDE prize, Laboratoire Guigoz, Département Hopsitalo-universitaire Risques et Grossesse, Université de Paris

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change of perineal pain assessed by the VAS (<H24) Perineal pain intensity, as a mean of several repeated self-reports measure of perineal pain (each 4 hours) on an 11-point visual analogue scale (VAS) from 0 to 10. From 2 to 24 hours after delivery
Secondary Rate of perineal laceration 1st, 2nd, 3rd and 4th (OASIS) degree perineal lacerations 2 hours after delivery
Secondary Rate of episiotomy episiotomy 2 hours after delivery
Secondary Perineal healing assessed by the REEDA scale Evaluation of perineal healing with the REEDA (redness, oedema, ecchymosis, discharge and approximation of the wound edges) scale: values from 0 to 15, higher scores meaning a worse perineal healing. 3 days after delivery
Secondary Change of perineal pain assessed by the VAS (<H96) Area under the curve of several repeated self-reports measure of perineal pain on an 11-point visual analogue scale (VAS) from 0 to 10. From delivery to 3 days after delivery
Secondary Consumptions of pain relief medications Number and type of pain relief medications consumed: paracetamol, nonsteroidal anti-inflammatory drugs, opioids, nefopam 3 days after delivery
Secondary Pain interference on daily functioning assessed by the BPI-SF Pain interference on daily functioning assessed by the Brief pain inventory-short form scale (BPI-SF), 7 items from the subscale 23, each item independently scored from 0 to 10, higher score meaning higher pain interference on daily functioning. 2 months after delivery
Secondary Perineal complication Number of health care appointments (in or outpatient care) for perineal reason (general practitioner, midwife, obstetrician-gynaecologist …) At two months postpartum
Secondary Childbirth experience assessed by the QACE Childbirth experience assessed by the Short version of the Questionnaire for Assessing the Childbirth Experience (QACE). Scores for the 13 items range from 1-4 with higher scores indicating a more negative childbirth experience. 3 days postpartum
Secondary Rate of exclusive breastfeeding Breastfeeding as exclusive mode of infant feeding At 3 days after delivery
Secondary Rate of exclusive breastfeeding Breastfeeding as exclusive mode of infant feeding At 2 months after delivery
Secondary Rate of breastfeeding complications Breastfeeding complications reported by women : breast engorgement, mastitis, breast abscess At 2 months after delivery
Secondary Urinary incontinence assessed with the ICIQ-UI SF Urinary incontinence assessed with the ICIQ - UI SF (International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form). Score ranges from 0 to 21, higher scores indicating higher urinary incontinence. At 2 months after delivery
Secondary Anal incontinence assessed with the Wexner Score Anal incontinence assessed with the Wexner Score. Score ranges from 0 to 20, higher scores indicating higher anal incontinence. At 2 months after delivery
Secondary Sexual function assessed with the FSFI Sexual function assessed by 4 items of the satisfaction et pain subscales of the FSFI (Female Sexual Function Index). Higher score for satisfaction (from 1 to 5) means higher satisfaction. Higher scores for pain items means higher pain (from 1 to 5). At 2 months after delivery
Secondary Rate of postpartum depression assessed by the EPDS Postpartum depression assessed with the Edinburgh postnatal depression scale (EPDS). Score ranges from 0 to 30, higher scores meaning more depressive symptoms. Postpartum depression will be defined by a score greater than 12. At 2 months after delivery
See also
  Status Clinical Trial Phase
Completed NCT04077801 - Effect Of Chronic Pelvic Pain on Lumbopelvic Alignment And TemproMandibular Joint Kinematics in Women
Completed NCT03740932 - Effect of Biomechanical Alignment and Jaw on Women With Pelvic Pain
Completed NCT04081532 - The Effectiveness of Laparoscopic Treatment of Superficial Endometriosis for Managing Chronic Pelvic Pain N/A
Recruiting NCT06101303 - Endometriosis Pain
Recruiting NCT03868137 - Multi-dose Ibuprofen Prophylaxis for IUD-insertion N/A
Suspended NCT04069572 - Vibratory Stimulation for the Treatment of Chronic Pain N/A
Completed NCT02547857 - Transvaginal Pelvic Ultrasound in the ED N/A
Completed NCT02923245 - POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound N/A
Completed NCT01938092 - Vaginal Diazepam for the Treatment of Female Pelvic Pain Phase 2
Active, not recruiting NCT01731470 - Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS) N/A
Completed NCT01421641 - Tenaculum Pain Control Study Phase 4
Completed NCT00034047 - Endometriosis : Traditional Medicine vs Hormone Therapy Phase 1/Phase 2
Completed NCT05368155 - Chronic Pelvic Pain and Education Skills Training for Women Veterans N/A
Completed NCT04179149 - Enriched Environments in Endometriosis N/A
Not yet recruiting NCT05530681 - Correlation Pelvic Floor Function and Ultrasound Findings One Year After Childbirth N/A
Completed NCT04077775 - Temporomandibular Joint Kinematics Changes in Pregnant Women: A Case-control Study
Completed NCT03715777 - Electromyographic Study for the Help and Guidance of BoNTA Administration in the Treatment of Chronic Pelvic Floor Pain Phase 3
Recruiting NCT05926752 - Photobiomodulation for Myofascial Pelvic Pain N/A
Completed NCT02588885 - Restoring Emotional, Sexual, and Physical Empowerment Through CBT & Trauma-sensitive Care: A Chronic Pelvic Pain Intervention N/A
Completed NCT02261740 - Program to Overcome Pelvic Pain With Yoga N/A